Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorMelphalanCombined Modality TherapyLeukapheresisHematologic NeoplasmsAntigens, CD34Blood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsBone Marrow TransplantationGraft vs Host DiseaseMyeloablative AgonistsBusulfanTreatment OutcomeGraft SurvivalLymphoma, Non-HodgkinHematopoietic Stem CellsEtoposideThiotepaRemission InductionAntineoplastic Agents, AlkylatingRecurrenceCarmustineCytophagocytosisIfosfamideSalvage TherapyVincristineAmyloidosisHematopoiesisCord Blood Stem Cell TransplantationStem CellsCytarabineTransplantation ChimeraHodgkin DiseaseDisease-Free SurvivalTissue DonorsGranulocytesRetrospective StudiesSurvival RateNeoplasmsWhole-Body IrradiationLiver TransplantationTime FactorsSurvival AnalysisInfectionHistocompatibilityLymphoma, T-CellDoxorubicinImmunosuppressive AgentsPlatelet CountHistocompatibility TestingTransplantation, IsogeneicPOEMS SyndromePrednisoneLeukemia, Myeloid, AcuteCarboplatinFollow-Up StudiesVidarabineDexamethasoneRecombinant ProteinsLeukemiaBlood Cell CountBone Marrow PurgingKidney TransplantationAntineoplastic AgentsCytomegalovirus InfectionsProspective StudiesLymphomaBlood Transfusion, AutologousBlood CellsGraft vs Leukemia EffectFatal OutcomeFeasibility StudiesAnemia, AplasticMyelodysplastic SyndromesImmunophenotypingT-LymphocytesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionCell TransplantationBone MarrowImmunosuppressionCyclosporineHLA AntigensLeukocytes, MononuclearHematologic DiseasesTransplantation ImmunologyMesenchymal Stem Cell TransplantationPrognosisPrecursor Cell Lymphoblastic Leukemia-LymphomaOpportunistic InfectionsHeart Transplantation